This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sigurdardottir, T.
Right arrow Articles by Bodelsson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sigurdardottir, T.
Right arrow Articles by Bodelsson, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 2983-2989, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.01583-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37

Thorgerdur Sigurdardottir,1 Pia Andersson,1 Mina Davoudi,2 Martin Malmsten,3 Artur Schmidtchen,2 and Mikael Bodelsson1*

Section of Anesthesiology and Intensive Care,1 Section for Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-221 85 Lund, Sweden,2 Department of Pharmacy, Uppsala University, Box 580, SE-751 23 Uppsala, Sweden3

Received 13 December 2005/ Returned for modification 15 March 2006/ Accepted 2 July 2006

Bacterial lipopolysaccharides (LPS) are important triggers of the widespread inflammatory response, which contributes to the development of multiple organ failure during sepsis. The helical 37-amino-acid-long human antimicrobial peptide LL-37 not only possesses a broad-spectrum antimicrobial activity but also binds and neutralizes LPS. However, the use of LL-37 in sepsis treatment is hampered by the fact that it is also cytotoxic. To find a less toxic analog of LL-37, we used in silico analysis to identify amphipathic helical regions of LL-37. A 21-amino-acid fragment (GKE) was synthesized, the biological actions of which were compared to those of two equally long peptides derived from the N and C termini of LL-37 as well as native LL-37. GKE displayed antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Candida parapsilosis that was similar to or even stronger than LL-37. GKE, as well as the equally long control peptides, attracted granulocytes in a fashion similar to that of LL-37, while only GKE was as potent as LL-37 in inhibiting LPS-induced vascular nitric oxide production. GKE caused less hemolysis and apoptosis in human cultured smooth muscle cells than LL-37. In summary, we have identified an active domain of LL-37, GKE, which displays antimicrobial activity in vitro and LPS-binding activity similar to those of LL-37 but is less toxic. GKE therefore holds promise as a template for the development of peptide antibiotics for the treatment of sepsis.

* Corresponding author. Mailing address: Department of Anesthesia and Intensive Care, University Hospital, SE-221 85 Lund, Sweden. Phone: 46 46 17 19 49. Fax: 46 46 17 60 50. E-mail: mikael.bodelsson{at}med.lu.se.

Antimicrobial Agents and Chemotherapy, September 2006, p. 2983-2989, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.01583-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Epand, R. F., Wang, G., Berno, B., Epand, R. M. (2009). Lipid Segregation Explains Selective Toxicity of a Series of Fragments Derived from the Human Cathelicidin LL-37. Antimicrob. Agents Chemother. 53: 3705-3714 [Abstract] [Full Text]  
  • Stromstedt, A. A., Pasupuleti, M., Schmidtchen, A., Malmsten, M. (2009). Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37. Antimicrob. Agents Chemother. 53: 593-602 [Abstract] [Full Text]  
  • Wang, G. (2008). Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid Micelles. J. Biol. Chem. 283: 32637-32643 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»